Arkolith/Insider Trading/SMNR/Form 4

Scilex Holding Co

10% OwnerSemnur Pharmaceuticals, Inc. (SMNR) · full profile →Form 4 · filed Sep 25, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$200.0M
Net Open-Market Flow
-$200.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 23, 2025Sell(S)555K$16.00$8.9M500K
Sep 23, 2025Sell(S)11.9M$16.00$191.1M181.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-218151) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML